POSITION:HOME > News

The review group consisting of the examiner Li Yonghao from South Korea FDA (food and drug administration), president Li Maojing of the Tian Jiquan South Korean company, Director Tian Fuzi of the South Korean Tianjiquan company, etc. came to Shenzhen Tianjiquan Health Technology Group to conduct   annual review on GMP(Good Manufacture Practice of Drugs). The review group's coming to Shenzhen to review this time reflects the Tianjiquan Group's confidence in the production and quality management, and also adds one layer of favorable safeguard for the consumers.

It is reported that South Korea review group will remain in Shenzhen until November 26th, and will review the production, inspection and storage conditions of Tianjiquan SLT semiconductor laser therapeutic instrument and 2015 annual product development information of the technical department, etc. according to South Korea Medical Devices Act, Chinese GMP, etc..

    On 23rd, the review group came to Futian headquarters of Tianjiquan Group to understand Tianjiquan enterprise culture and enterprise development process.

From 24th to 26th, together with the Management personnel of the industrial park , the review group   took the method of focusing on the on-site review, supplemented by the document review to review the important links such as product production, finished products inspection, storage, etc. in Tianjiquan Guanlan Industrial Park Zone. After the comprehensive assessment by the review group, Shenzhen Tianjiquan Health Technology Group conforms to GMP (Good Manufacture Practice of Drugs)

Tianjiquan has always had strict standard in quality control of, and also had strict requirements for production, inspection and storage to ensure the quality of products and services through a series of links such as procurement, quality control, storage, etc. and provide consumers with the best products and services.

 

Examiner  Li Yonghao of South Korea FDA (food and drug administration),  president Li Maojing of the South Korean Tianjiquan company, Director Tian Fuzi of the South Korean company visit the head office of Tianjiquan Group

 

 

Examiner  Li Yonghao from South Korea FDA (food and drug administration), president Li Maojing of the South Korean Tian Jiquan company visit the head office of Tianjiquan Group

 

Present Li Maojing, Director Tian Fuzi of the South Korean company visit the head office of Tianjiquan Group

 

Examiner  Li Yonghao of South Korea FDA (food and drug administration), president Li Maojing, Director Tian Fuzi of the South Korean Company talk with chairman Shi Yanbao, deputy chairmen Zhan Laixing,  managing director Li Yupeng of Tianjiquan Group.

 

Examiner Li Yonghao of South Korea FDA (food and drug administration), president Li Maojing, Director Tian Fuzi of the South Korean Tian Jiquan Company try the new product of the company

 

South Korean review group conduct on-site review in Tianjiquan Guanlan Industrial Park

 

South Korean review group conduct on-site review in Tianjiquan Guanlan Industrial Park

 

South Korean review group conduct on-site review in Tianjiquan Guanlan Industrial Park

 

South Korean review group conduct documents review in Tianjiquan Guanlan Industrial Park

 

South Korean review group conduct on-site review in Tianjiquan Guanlan Industrial Park